Skip to content

The Application of Nitric Oxide Combined with High-Flow Nasal Cannula Oxygen Therapy in Patients with Acute Respiratory Failure

The Application of Nitric Oxide Combined with High-Flow Nasal Cannula Oxygen Therapy in Patients with Acute Respiratory Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115734
Enrollment
Unknown
Registered
2025-12-30
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure

Interventions

HFNC+iNO Group:Inhaled Nitric Oxide Combined with High-Flow Nasal Cannula Oxygen Therapy

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old; 2.Sign the informed consent form; 3.P/F= 24 hours.

Exclusion criteria

Exclusion criteria: 1.Known pregnancy; 2.A history of cerebral hemorrhage within the past six months, or circulatory instability caused by active bleeding; 3.Large - volume pleural effusion without drainage, and tension pneumothorax; 4.Refractory shock; 5.Acquired immunodeficiency syndrome (HIV); 6.Congenital methemoglobinemia; 7.Severe hypoplastic left heart syndrome, life - threatening congenital defects, and congestive heart failure.

Design outcomes

Primary

MeasureTime frame
28-day invasive mechanical ventilation rate;

Secondary

MeasureTime frame
Index of oxygenation, P/F;Region of Interest (ROI);Arterial partial pressure of carbon dioxide, PaCO2;Platelet Aggregation Rate;Soluble intercellular adhesion molecule-1;End-expiratory lung impedance (EELI);Renal Resistive Index (RRI);Global Inhomogeneity(GI);Tidal impedance variation (TIV);P-Selectin;Local over - expansion/collapse (ODCL);Arterial partial pressure of oxygen, PaO2;Activated protein C;

Countries

China

Contacts

Public ContactHongping Qu

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

hongpingqu0412@hotmail.com+86 21 64370045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026